Dental Product Regulation

Overview

To help clarify and provide context on oral health issues and dental products, the ADA provides scientific evidence, information and commentary to a wide variety of audiences including the dental profession, media, government agencies and the public. The links below provide access to Association's communications on a number dental product issues.

Click on this link to learn about recent oral health safety alerts.

Letters & Testimony

• July 28, 2011—Coalition letter expressing support for S. 296 and its House companion, H.R. 2245, the Preserving Access to Life-Saving Medications Act.
• April 25, 2011—Letter urging the Food and Drug Administration to address the oral complications associated with reduced salivary flow on the warning labels of medications commonly associated with dry mouth.
• July 2010—Statement on dental products and BPA exposure.
• November 20, 2009—News Release on the ADA's petition to the FDA to establish and appropriate regulatory classification for tooth whitening chemicals.
• March 24, 2009—News Release announcing the results of the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
• March 16, 2009—Letter informing CDC about the data obtained from the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
• March 16, 2009—Letter informing FDA about the data obtained from the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
• December 8, 2008—Letter responding to the FDA's call for comments on the identification of FDA-regulated products that contain bisphenol A (BPA).
• May 23, 2008—Letter commenting on the National Toxicology Program's Draft Brief on BPA.
• April 29, 2008—News Release on safety concerns raised by media reports about lead in dental prosthetics such as crowns and bridges.
• March 18, 2008—Letter urging CDC to assure the public that government agencies are taking appropriate steps to protect dental patients from any possible health impacts of lead in dental prosthetics and that oral health care should not be postponed.
• March 18, 2008—Letter urging FDA to assure the public that government agencies are taking appropriate steps to protect dental patients from possible health impacts of lead in dental prosthetics and that oral health care should not be postponed.
• March 6, 2008—Letter informing CDC that the ADA will be carrying out an independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
• March 6, 2008—Letter informing FDA that the ADA will be carrying out an independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.

ADA Resources

• ADA Positions and Statements
• Safety Alerts
• Amalgam (Dental Filling Options)
• Braces and Orthodontics
• Bridges
• Crowns
• Dentures / Partial Dentures, Removable
• Fluoride Supplements
• Grills (Dental)
• Implants
• Lasers
• Mouthguards
• Sealants / Pit-and-Fissure Sealants / Bisphenol A
• Space Maintainers
• Tooth Whitening Treatments
• Veneers
• X-rays/Radiography

Additional Resources

• Centers for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• National Institute of Dental and Craniofacial Research (NIDCR)

Contact Us

For additional information, please contact:

• Robert J. Burns, Federal Affairs
• Jennifer Fisher, Congressional Affairs
• Jerry Bowman, State Government Affairs

Federal Affairs
1111 14th Street NW, Suite 1100
Washington, DC 20005
202.898.2400
Fax: 202.898.2437
E-mail: govtpol@ada.org

State Government Affairs
ADA Chicago Headquarters
211 East Chicago Avenue
Chicago, IL 60611
312.440.2525
Fax: 312.440.3539
E-mail: govtpol@ada.org